Skip to main content

Tango Therapeutics, Inc 10-Q for FY2023 Q2

Tango Therapeutics, Inc. (TNGX)

10-Q 2023-08-07 For: 2023-06-30
View Original
Added on April 08, 2026

About this 10-Q

Tango Therapeutics, Inc filed this 10-Q on August 7, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).

Headline figures

Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$14.6M
up 153.0% from $5.77M a year earlier
Net loss
$20.71M
compared with a net loss of $24.86M a year earlier
Diluted EPS
-$0.23
compared with -$0.28 a year earlier